Wealth Enhancement Advisory Services’s MaxCyte MXCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$76.3K Buy
57,390
+30,965
+117% +$30.9K ﹤0.01% 3852
2026
Q1
$19.8K Buy
+26,425
New +$24.7K ﹤0.01% 3503

Other funds holding MXCT

Wealth Enhancement Advisory Services's MXCT Position: Q2 2026 in Review

Wealth Enhancement Advisory Services increased its MaxCyte (MXCT) stake by 117% in Q2 2026, buying an estimated $30.9K and bringing the position to 57,390 shares worth $76.3K. The position accounts for ﹤0.01% of the portfolio, ranked #3852.

Wealth Enhancement Advisory Services first reported a position in MXCT in Q1 2026 and has held it in 2 quarters since. 8 funds tracked by Wall St. Rank hold MXCT as of Q2 2026.

  • Wealth Enhancement Advisory Services held 57,390 shares of MaxCyte worth $76.3K as of Q2 2026.
  • Wealth Enhancement Advisory Services bought 30,965 MaxCyte shares in Q2 2026, an estimated $30.9K.
  • MaxCyte made up ﹤0.01% of Wealth Enhancement Advisory Services's portfolio in Q2 2026, its #3852 holding.
  • Wealth Enhancement Advisory Services first reported a position in MaxCyte in Q1 2026 and has held it in 2 quarters since.
  • 8 funds tracked by Wall St. Rank held MaxCyte as of Q2 2026.

Based on Wealth Enhancement Advisory Services's 13F filing for Q2 2026, filed 15 Jul 2026.